CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
shares in Thousands, $ in Thousands |
Total |
Common Stock |
Treasury Stock |
Paid-in Capital |
Accumulated Other Comprehensive Loss, net of tax |
Accumulated Deficit |
| Beginning balance (in shares) at Dec. 31, 2023 |
|
20,449
|
|
|
|
|
| Beginning balance at Dec. 31, 2023 |
$ (20,442)
|
$ 20
|
$ (174,702)
|
$ 229,680
|
$ (22)
|
$ (75,418)
|
| Beginning balance (in shares) at Dec. 31, 2023 |
|
|
4,921
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares) |
|
|
(84)
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan |
(371)
|
|
$ 3,011
|
(3,382)
|
|
|
| Non-cash stock compensation |
1,190
|
|
|
1,190
|
|
|
| Net income (loss) |
(9,460)
|
|
|
|
|
(9,460)
|
| Other comprehensive income (loss), net of tax |
(18)
|
|
|
|
(18)
|
|
| Ending balance (in shares) at Apr. 21, 2024 |
|
20,449
|
|
|
|
|
| Ending balance at Apr. 21, 2024 |
(29,101)
|
$ 20
|
$ (171,691)
|
227,488
|
(40)
|
(84,878)
|
| Ending balance (in shares) at Apr. 21, 2024 |
|
|
4,837
|
|
|
|
| Beginning balance (in shares) at Dec. 31, 2023 |
|
20,449
|
|
|
|
|
| Beginning balance at Dec. 31, 2023 |
(20,442)
|
$ 20
|
$ (174,702)
|
229,680
|
(22)
|
(75,418)
|
| Beginning balance (in shares) at Dec. 31, 2023 |
|
|
4,921
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Net income (loss) |
(37,825)
|
|
|
|
|
|
| Other comprehensive income (loss), net of tax |
(12)
|
|
|
|
|
|
| Ending balance (in shares) at Oct. 06, 2024 |
|
20,449
|
|
|
|
|
| Ending balance at Oct. 06, 2024 |
(53,337)
|
$ 20
|
$ (165,747)
|
225,666
|
(33)
|
(113,243)
|
| Ending balance (in shares) at Oct. 06, 2024 |
|
|
4,670
|
|
|
|
| Beginning balance (in shares) at Apr. 21, 2024 |
|
20,449
|
|
|
|
|
| Beginning balance at Apr. 21, 2024 |
(29,101)
|
$ 20
|
$ (171,691)
|
227,488
|
(40)
|
(84,878)
|
| Beginning balance (in shares) at Apr. 21, 2024 |
|
|
4,837
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares) |
|
|
(143)
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan |
187
|
|
$ 5,106
|
(4,919)
|
|
|
| Non-cash stock compensation |
1,856
|
|
|
1,856
|
|
|
| Net income (loss) |
(9,489)
|
|
|
|
|
(9,489)
|
| Other comprehensive income (loss), net of tax |
4
|
|
|
|
4
|
|
| Ending balance (in shares) at Jul. 14, 2024 |
|
20,449
|
|
|
|
|
| Ending balance at Jul. 14, 2024 |
(36,543)
|
$ 20
|
$ (166,585)
|
224,425
|
(36)
|
(94,367)
|
| Ending balance (in shares) at Jul. 14, 2024 |
|
|
4,694
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares) |
|
|
(24)
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan |
(59)
|
|
$ 838
|
(897)
|
|
|
| Non-cash stock compensation |
2,138
|
|
|
2,138
|
|
|
| Net income (loss) |
(18,876)
|
|
|
|
|
(18,876)
|
| Other comprehensive income (loss), net of tax |
3
|
|
|
|
3
|
|
| Ending balance (in shares) at Oct. 06, 2024 |
|
20,449
|
|
|
|
|
| Ending balance at Oct. 06, 2024 |
$ (53,337)
|
$ 20
|
$ (165,747)
|
225,666
|
(33)
|
(113,243)
|
| Ending balance (in shares) at Oct. 06, 2024 |
|
|
4,670
|
|
|
|
| Beginning balance (in shares) at Dec. 29, 2024 |
17,403
|
22,050
|
|
|
|
|
| Beginning balance at Dec. 29, 2024 |
$ (84,269)
|
$ 22
|
$ (164,937)
|
233,667
|
(62)
|
(152,959)
|
| Beginning balance (in shares) at Dec. 29, 2024 |
4,647
|
|
4,647
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares) |
|
|
(335)
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan |
$ 241
|
|
$ 11,993
|
(11,752)
|
|
|
| Non-cash stock compensation |
2,365
|
|
|
2,365
|
|
|
| Net income (loss) |
1,249
|
|
|
|
|
1,249
|
| Other comprehensive income (loss), net of tax |
2
|
|
|
|
2
|
|
| Ending balance (in shares) at Apr. 20, 2025 |
|
22,050
|
|
|
|
|
| Ending balance at Apr. 20, 2025 |
$ (80,412)
|
$ 22
|
$ (152,944)
|
224,280
|
(60)
|
(151,710)
|
| Ending balance (in shares) at Apr. 20, 2025 |
|
|
4,312
|
|
|
|
| Beginning balance (in shares) at Dec. 29, 2024 |
17,403
|
22,050
|
|
|
|
|
| Beginning balance at Dec. 29, 2024 |
$ (84,269)
|
$ 22
|
$ (164,937)
|
233,667
|
(62)
|
(152,959)
|
| Beginning balance (in shares) at Dec. 29, 2024 |
4,647
|
|
4,647
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Net income (loss) |
$ (13,177)
|
|
|
|
|
|
| Other comprehensive income (loss), net of tax |
$ 2
|
|
|
|
|
|
| Ending balance (in shares) at Oct. 05, 2025 |
17,966
|
22,050
|
|
|
|
|
| Ending balance at Oct. 05, 2025 |
$ (96,090)
|
$ 22
|
$ (144,772)
|
214,856
|
(60)
|
(166,136)
|
| Ending balance (in shares) at Oct. 05, 2025 |
4,084
|
|
4,084
|
|
|
|
| Beginning balance (in shares) at Apr. 20, 2025 |
|
22,050
|
|
|
|
|
| Beginning balance at Apr. 20, 2025 |
$ (80,412)
|
$ 22
|
$ (152,944)
|
224,280
|
(60)
|
(151,710)
|
| Beginning balance (in shares) at Apr. 20, 2025 |
|
|
4,312
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares) |
|
|
(148)
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan |
230
|
|
$ 5,299
|
(5,069)
|
|
|
| Non-cash stock compensation |
(2,454)
|
|
|
(2,454)
|
|
|
| Net income (loss) |
3,993
|
|
|
|
|
3,993
|
| Ending balance (in shares) at Jul. 13, 2025 |
|
22,050
|
|
|
|
|
| Ending balance at Jul. 13, 2025 |
(78,643)
|
$ 22
|
$ (147,645)
|
216,757
|
(60)
|
(147,717)
|
| Ending balance (in shares) at Jul. 13, 2025 |
|
|
4,164
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares) |
|
|
(80)
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan |
0
|
|
$ 2,873
|
(2,873)
|
|
|
| Non-cash stock compensation |
972
|
|
|
972
|
|
|
| Net income (loss) |
(18,419)
|
|
|
|
|
(18,419)
|
| Other comprehensive income (loss), net of tax |
$ 0
|
|
|
|
|
|
| Ending balance (in shares) at Oct. 05, 2025 |
17,966
|
22,050
|
|
|
|
|
| Ending balance at Oct. 05, 2025 |
$ (96,090)
|
$ 22
|
$ (144,772)
|
$ 214,856
|
$ (60)
|
$ (166,136)
|
| Ending balance (in shares) at Oct. 05, 2025 |
4,084
|
|
4,084
|
|
|
|